Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

DANAZOL

DANAZOL

Standard Dose
50MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Prescription
Summary

Approval overview DANAZOL is listed in Drugs@FDA under application 078214 (ANDA).

Marketing status: Prescription Active ingredient DANAZOL Form and strength CAPSULE;ORAL - 50MG Sponsor LANNETT Submission history Latest submission status date: 2012-03-15 00:00:00.

Structured Monograph

Clinical summary

Approval overview DANAZOL is listed in Drugs@FDA under application 078214 (ANDA). Marketing status: Prescription Active ingredient DANAZOL Form and strength CAPSULE;ORAL - 50MG Sponsor LANNETT Submission history Latest submission status date: 2012-03-15 00:00:00. Submission type: SUPPL.

Monitoring

  • • Review priority: STANDARD
  • • Marketing status: Prescription

Interaction Notes

  • No interaction notes stored yet.